ALB and cocaine dependence: Our computationally designed, discovered, and patented first CocH, denoted as CocH1 (i.e. the A199S/S287G/A328W/Y332G mutant)37,46–48, has been truncated after amino-acid residue #529 and fused with human serum albumin (HSA or Albu)41,49 to extend its biological half-life for clinical development to treat cocaine dependence.